Suppr超能文献

肠道微生物群会影响减肥的成效吗?证据与推测。

Does gut microbiota affect the success of weight loss? Evidence and speculation.

作者信息

Moszak Małgorzata, Pelczyńska Marta, Wesołek Agnieszka, Stenclik Dominika, Bogdański Paweł

机构信息

Department of Treatment of Obesity, Metabolic Disorders and Clinical Dietetics, Poznan University of Medical Sciences, Poznan, Poland.

Department of Treatment of Obesity, Metabolic Disorders and Clinical Dietetics, Poznan University of Medical Sciences, Poznan, Poland.

出版信息

Nutrition. 2023 Dec;116:112111. doi: 10.1016/j.nut.2023.112111. Epub 2023 May 31.

Abstract

Obesity is a chronic state of excessive fat accumulation in the body, characterized by significant relapse and complicated by a range of health consequences. In the treatment of obesity, a holistic approach including diet, physical activity, pharmacotherapy, bariatric surgery, and psychological support is recommended. The implications of gut microbiota (GM) as a pathogenic factor in excess body weight have been discussed, and microbial-targeted therapies-including probiotics, prebiotics, and synbiotics-are considered adjuvant in obesity management. Many studies have focused on assessing the effectiveness of probiotics, prebiotics, or synbiotics in weight control, although with inconclusive results, mainly because of the significant heterogeneity of the studies (with different strains, doses, forms, interventional durations, and outcomes). It is also unclear whether using probiotics or synbiotics accompanied by weight loss dietary interventions or as a part of bariatric surgery will be more effective in obesity management, not only in the short-term but also for long-term weight loss maintenance. The aim of this study was to collect and compare the available scientific data on the effectiveness of probiotic or synbiotic supplementation (as a single therapy versus as part of dietary interventions, pharmacotherapy, or bariatric therapy) on weight control in obesity.

摘要

肥胖是一种身体脂肪过度积累的慢性状态,其特点是显著复发,并伴有一系列健康后果。在肥胖治疗中,建议采用包括饮食、体育活动、药物治疗、减肥手术和心理支持在内的整体方法。肠道微生物群(GM)作为体重超标致病因素的影响已被讨论,包括益生菌、益生元及合生元在内的微生物靶向疗法被视为肥胖管理的辅助手段。许多研究聚焦于评估益生菌、益生元或合生元在体重控制方面的有效性,不过结果尚无定论,主要原因是研究存在显著异质性(不同菌株、剂量、形式、干预持续时间和结果)。同样不清楚的是,使用益生菌或合生元并配合减肥饮食干预,或作为减肥手术的一部分,在肥胖管理中是否不仅在短期内,而且在长期维持体重减轻方面会更有效。本研究的目的是收集并比较关于补充益生菌或合生元(作为单一疗法以及作为饮食干预、药物治疗或减肥治疗的一部分)对肥胖患者体重控制有效性的现有科学数据。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验